UBS Thinks AbbVie's Valuation Is 'Interesting' By: Benzinga via Benzinga February 02, 2015 at 11:18 AM EST UBS commented on AbbVie Inc (NYSE: ABBV) Friday and maintained a Buy rating with a $76 price target following the company’s Q4 ... Read More >> Related Stocks: AbbVie UBS Group Ag ADR